Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value
$2.81B
Total Bought
$14.59M
Total Sold
$705.92M
Net Transaction
-$691.33M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
DLOCAL(DLO)63,906,69563,906,6950511,254719,58925.61%+208,336
CENTESSA PHARMACEUTICALS9,681,8189,681,8180154,812162,1705.77%+7,358
ADAGENE264,0003,825,952+3,561,9525867,6140.27%+7,028
PHARVARIS
COM
7,531,2527,531,2520139,479144,3745.14%+4,895
GROVE COLLABORATIVE(GROV)936,0202,474,859+1,538,8391,2643,4400.12%+2,176
WISH609,616609,61603,3224,2860.15%+963
RISKIFIED(RSKD)5,324,9985,324,998025,18725,1870.90%0
EUROPEAN WAX CENTER
CLASS A COM
13,110,49213,110,492089,15187,4473.11%-1,704
IMMUNOCORE(IMCR)1,261,6841,261,684039,27637,2201.32%-2,057
ROYALTY PHARMA(RPRX)1,500,0001,500,000042,43538,2651.36%-4,170
AKERO THERAPEUTICS5,233,9895,233,9890150,163145,6105.18%-4,554
THIRD HARMONIC BIO2,958,7623,372,323+413,56140,09134,7011.24%-5,390
ACELYRIN2,889,6682,695,327-194,34114,2468,4630.30%-5,783
ALIGNMENT HEALTHCARE(ALHC)60,993,32360,993,3230720,941686,17524.43%-34,766
BLEND LABS(BLND)19,132,4400-19,132,44071,7470—-71,747
ALKAMI(ALKT)15,520,3189,645,318-5,875,000489,511353,79012.59%-135,721
XP, INC(XP)29,617,73329,617,7330531,342350,97012.49%-180,372
SQUARESPACE10,611,0730-10,611,073492,6720—-492,672
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q4 2024 | TickerTrail